Ranitidine Market to Experience Steady Growth with Notable CAGR 2.5% and Market Value US$ 562.09 million by 2030 Surge
Posted July 18, 2023 by nikita07072002
Ranitidine Market, By Strength (75 mg, 150 mg, and 300 mg), By Indication (Intestinal& Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), By Dosage Form (Tablets, Syrups, and Injections)
Feature News
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/135
Key Highlights:
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the recall of all forms of Zantac (ranitidine) from the market, due to concerns about cancer risks. This was the final step in over a year of investigations and studies on the drug that linked it with N-nitrosodimethylamine (NDMA), a cancer-causing agent.
-- END ---
| Contact Email | [email protected] |
| Issued By | nikita |
| Phone | 91 7775049802 |
| Business Address | BadilloStreet |
| Country | United States |
| Categories | Health |
| Tags | ranitidine market trends |
| Last Updated | July 18, 2023 |